Navigation Links
New breast cancer stem cell findings explain how cancer spreads
Date:1/14/2014

ANN ARBOR, Mich. Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes cancer a deadly disease.

"The lethal part of cancer is its metastasis so understanding how metastasis occurs is critical," says senior study author Max S. Wicha, M.D., Distinguished Professor of Oncology and director of the University of Michigan Comprehensive Cancer Center. "We have evidence that cancer stem cells are responsible for metastasis they are the seeds that mediate cancer's spread. Now we've discovered how the stem cells do this."

First, on the outside of the tumor, a type of stem cell exists in a state called the epithelial-mesenchymal transition (EMT) state. These stem cells appear dormant but are very invasive and able to get into the bloodstream, where they travel to distant parts of the body.

Once there, the stem cells transition to a second state that displays the opposite characteristics, called the mesenchymal-epithelial transition state (MET). These cells are capable of growing and making copies of themselves, producing new tumors.

"You need both forms of cancer stem cells to metastasize and grow in distant organs. If the stem cell is locked in one or the other state, it can't form a metastasis," Wicha says.

The findings, which are published in the January issue of Stem Cell Reports, raise a number of questions about how to treat or prevent metastatic breast cancer. Researchers must now understand whether new therapies must attack both forms of the stem cell to be successful. Different pathways regulate each type of stem cell, which suggests that effective therapies must be able to target multiple pathways.

In addition, current tests that look at tumor cells circulating in the blood to help determine whether the cancer is spreading do not appear to capture the EMT stem cells, which are the cancer cells that travel through the blood. U-M researchers are working with colleagues from the U-M College of Engineering to develop new tools to isolate the EMT stem cells from the blood of cancer patients.

"Now that we know we are looking at two different states of cancer stem cells, we can use markers that distinguish these states to get a better sense of where the cancer stem cells are and to determine the effectiveness of our treatments," Wicha says.

The study looked specifically at breast cancer stem cells but the researchers believe the findings likely have implications for other cancer types as well.


'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Related biology news :

1. Novel noninvasive therapy prevents breast cancer formation in mice
2. Breast cancer patients experience fewer side effects from anticancer drug when receiving acupuncture
3. Role for sugar uptake in breast cancer revealed
4. Deep sequencing of breast cancer tumors to predict clinical outcomes after single dose of therapy
5. Cyclin D1 governs microRNA processing in breast cancer
6. High cholesterol fuels the growth and spread of breast cancer
7. LSUHSC research finds combo of plant nutrients kills breast cancer cells
8. Nanoparticles can overcome drug resistance in breast cancer cells
9. Breastfeeding as a possible deterrent to autism -- a clinical perspective
10. Study: Metformin for breast cancer less effective at higher glucose concentrations
11. Mutations in novel tumor suppressor gene associated with early onset breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New breast cancer stem cell findings explain how cancer spreads
(Date:7/9/2019)... Del. (PRWEB) , ... July 08, 2019 , ... ... Court ruled in favor of Danisco’s ownership of the innovation behind two Danisco ... that an entitlement action could be based on prior art was without merit ...
(Date:6/25/2019)... ... , ... ActX has launched a medical genetic interpretation ... can get access to professionally reviewed genetic screening similar to what a physician ... + Ancestry customers., With the ActX + 23andMe service, both 23andMe customers and ...
(Date:6/19/2019)... LAS VEGAS (PRWEB) , ... June 19, 2019 , ... ... on improving physicochemical properties of Cefazolin Sodium, antibiotic which can prove to be beneficial ... Over 519% increase in residue amount , Over 68% decrease in ...
Breaking Biology News(10 mins):
(Date:6/26/2019)... ... June 26, 2019 , ... Alice Branton today released research results from preclinical ... Magnesium Gluconate, which can prove to be beneficial for treating Hypomagnesemia. , The preclinical ... change in crystallite size , Over 142% increase in particle size , ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology Ltd is pleased ... Biofeedback Tech Ltd as its authorised distributor for the UK and ... therapeutic treatments and clinical assessment protocols to treat stress related disorders as well ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... USPTO providing proprietary interest to our methodology, processes, and diagnostic techniques. The ... TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring methodology. The ...
Breaking Biology Technology: